A citation-based method for searching scientific literature

George Wright, Bruce Tan, Andreas Rosenwald, Elaine H Hurt, Adrian Wiestner, Louis M Staudt. Proc Natl Acad Sci U S A 2003
Times Cited: 721



G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal, J Vose, M Bast, K Fu, D D Weisenburger, T C Greiner, J O Armitage, A Kyle, L May, R D Gascoyne, J M Connors, G Troen, H Holte, S Kvaloy, D Dierickx, G Verhoef, J Delabie, E B Smeland, P Jares, A Martinez, A Lopez-Guillermo, E Montserrat, E Campo, R M Braziel, T P Miller, L M Rimsza, J R Cook, B Pohlman, J Sweetenham, R R Tubbs, R I Fisher, E Hartmann, A Rosenwald, G Ott, H-K Muller-Hermelink, D Wrench, T A Lister, E S Jaffe, W H Wilson, W C Chan, L M Staudt. N Engl J Med 2008
Times Cited: 1229




List of shared articles



Times cited

Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?
Ryan D Morin, Sarah E Arthur, Daniel J Hodson. Br J Haematol 2022
8

Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes, Itziar Salaverria, Ferran Nadeu, Juan Enric Ramis-Zaldivar, Juan G Valero, Alfredo Rivas-Delgado, Laura Magnano, David Martin-García,[...]. Br J Haematol 2022
0


Evolution of therapy for limited stage diffuse large B-cell lymphoma.
Alexandra E Rojek, Sonali M Smith. Blood Cancer J 2022
0


High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.
Dario Marino, Marco Pizzi, Iuliia Kotova, Ronny Schmidt, Christoph Schröder, Vincenza Guzzardo, Ilaria Talli, Edoardo Peroni, Silvia Finotto, Greta Scapinello,[...]. Cancers (Basel) 2022
0


Classifying Germinal Center Derived Lymphomas-Navigate a Complex Transcriptional Landscape.
Henry Loeffler-Wirth, Markus Kreuz, Maria Schmidt, German Ott, Reiner Siebert, Hans Binder. Cancers (Basel) 2022
0

BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
Elizabeth Punnoose, Franklin V Peale, Edith Szafer-Glusman, Guiyuan Lei, Richard Bourgon, An D Do, Eugene Kim, Liping Zhang, Pedro Farinha, Randy D Gascoyne,[...]. Clin Lymphoma Myeloma Leuk 2021
3


OBF1 and Oct factors control the germinal center transcriptional program.
Shuang Song, Chun Cao, Mohamed-Amin Choukrallah, Fengyuan Tang, Gerhard Christofori, Hubertus Kohler, Fabian Wu, Barna D Fodor, Mathias Frederiksen, Simon N Willis,[...]. Blood 2021
7

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Nikita Kotlov, Alexander Bagaev, Maria V Revuelta, Jude M Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva, Viktor Svekolkin, Ekaterina Tikhonova, Natalia Miheecheva, Natalia Kuzkina,[...]. Cancer Discov 2021
40

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin,[...]. J Clin Oncol 2021
45

Characterization of DLBCL with a PMBL gene expression signature.
Gerben Duns, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy S Hung, Elizabeth Chavez, Katsuyoshi Takata, Christopher Rushton, Aixiang Jiang, Susana Ben-Neriah,[...]. Blood 2021
7

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.
Stefano A Pileri, Claudio Tripodo, Federica Melle, Giovanna Motta, Valentina Tabanelli, Stefano Fiori, Maria Carmela Vegliante, Saveria Mazzara, Sabino Ciavarella, Enrico Derenzini. Cells 2021
4

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.
Anja Schmitt, Wendan Xu, Philip Bucher, Melanie Grimm, Martina Konantz, Heike Horn, Myroslav Zapukhlyak, Philipp Berning, Marc Brändle, Mohamed-Ali Jarboui,[...]. Blood 2021
17

Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features.
Marjukka Pollari, Suvi-Katri Leivonen, Sirpa Leppä. Cancers (Basel) 2021
2

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Wyndham H Wilson, George W Wright, Da Wei Huang, Brendan Hodkinson, Sriram Balasubramanian, Yue Fan, Jessica Vermeulen, Martin Shreeve, Louis M Staudt. Cancer Cell 2021
29

Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay.
Robert Ta, Chris Santini, Patricia Gou, Greg Lee, Yu Chuan Tai, Cathal O'Brien, Marcel Fontecha, Cliona Grant, Larry Bacon, Stephen Finn,[...]. J Mol Diagn 2021
1

Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma.
Etienne Leveille, Nathalie A Johnson. Cancers (Basel) 2021
4

Treatment resistance in diffuse large B-cell lymphoma.
Michael Y He, Robert Kridel. Leukemia 2021
10

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma.
Mengmeng Pan, Pingping Yang, Fangce Wang, Xiu Luo, Bing Li, Yi Ding, Huina Lu, Yan Dong, Wenjun Zhang, Bing Xiu,[...]. Front Genet 2021
0

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
Xiao-Jie Liang, Rui-Ying Fu, He-Nan Wang, Jing Yang, Na Yao, Xin-di Liu, Liang Wang. J Immunol Res 2021
4

Prognostic efficacy of the RTN1 gene in patients with diffuse large B-cell lymphoma.
Mohamad Zamani-Ahmadmahmudi, Seyed Mahdi Nassiri, Amir Asadabadi. Sci Rep 2021
1

Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma.
Grzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, David W Scott, Michele Spina, Randy D Gascoyne, Lei Zhang, Jacqueline Russo, Janet Kang, Jingshan Zhang,[...]. Haematologica 2020
5

In situ BCL2 expression is an independent prognostic factor in HIV-associated DLBCL, a LYMPHOVIR cohort study.
Laure Philippe, Remi Lancar, Camille Laurent, Michele Algarte-Genin, Catherine Chassagne-Clément, Bettina Fabiani, Marie Pierre Chenard, Thierry Lazure, Marie Parrens, Frederic Charlotte,[...]. Br J Haematol 2020
3

Gene Expression Profiling of B Cell Lymphoma in Dogs Reveals Dichotomous Metabolic Signatures Distinguished by Oxidative Phosphorylation.
Ying Wu, Yu-Mei Chang, Gerry Polton, Anneliese J Stell, Balazs Szladovits, Michael Macfarlane, Laureen M Peters, Simon L Priestnall, Nicholas J Bacon, Kelvin Kow,[...]. Front Oncol 2020
4

Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified.
Inju Cho, Nara Yoon, Jiyeon Hyeon, Jongmin Sim, Hae Yong Yoo, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko. Appl Immunohistochem Mol Morphol 2020
4


H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.
Kolja Schleich, Julia Kase, Jan R Dörr, Saskia Trescher, Animesh Bhattacharya, Yong Yu, Elizabeth M Wailes, Dorothy N Y Fan, Philipp Lohneis, Maja Milanovic,[...]. Nat Commun 2020
9

Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma.
Philip Bucher, Tabea Erdmann, Paula Grondona, Wendan Xu, Anja Schmitt, Christoph Schürch, Myroslav Zapukhlyak, Caroline Schönfeld, Edgar Serfling, Daniela Kramer,[...]. Blood 2020
14

Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent.
Alberto Risueño, Patrick R Hagner, Fadi Towfic, Celia Fontanillo, Amira Djebbari, Joel S Parker, Clifton P Drew, Grzegorz S Nowakowski, Matthew J Maurer, James R Cerhan,[...]. Blood 2020
9

Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.
Yuri Fedoriw, Sara Selitsky, Nathan D Montgomery, Sviatoslav M Kendall, Kristy L Richards, Wei Du, Tamiwe Tomoka, Maurice Mulenga, Joel S Parker, Sandeep S Dave,[...]. Mod Pathol 2020
3


A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.
Zijun Y Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Carlo Visco, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu,[...]. Blood Adv 2020
7

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Jordan E Krull, Kerstin Wenzl, Keenan T Hartert, Michelle K Manske, Vivekananda Sarangi, Matthew J Maurer, Melissa C Larson, Grzegorz S Nowakowski, Stephen M Ansell, Ellen McPhail,[...]. Blood Cancer J 2020
4

Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study.
Michael Schaffer, Shalini Chaturvedi, Cuc Davis, Jan de Jong, Regina Aquino, Yasuhiro Oki, Nele Fourneau, Anas Younes, Sriram Balasubramanian. Cancer Treat Res Commun 2020
1

Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Jeff P Sharman, Andres Forero-Torres, Luciano J Costa, Ian W Flinn, Lowell Inhorn, Kevin Kelly, Alberto Bessudo, Luis E Fayad, Mark S Kaminski, Andrew M Evens,[...]. Leuk Lymphoma 2019
11

Profiling of lymphoma from formalin-fixed paraffin-embedded tissue.
Ryan S Robetorye, Alanna Maguire, Alison C Rosenthal, Lisa M Rimsza. Semin Hematol 2019
3